Proxinome focuses on using various culture models to analyze the mechanistic pathways of disease progression.
The company employs a proprietary Dynactic analysis methodology at multiple timepoints through the course of disease. This analysis results in identifying the location and expression of genes involved in the pathological process.
Through this approach, Proxinome intends to identify optimal drug targets that can be used to develop therapeutic agents, as well as identify critical treatment time windows in which further cancer deterioration can be inhibited or tissue regeneration can occur.
Contact us at 650-903-2243 for more information, or fill out our contact form.
© 2002 Proxinome
All Rights Reserved.